ConcertAI
About ConcertAI
ConcertAI is a leading healthcare AI company dedicated to accelerating insights and improving patient outcomes through the application of real-world data (RWD), advanced AI technologies, and scientific expertise. For physicians, this translates into powerful tools designed to enhance clinical decision-making, streamline research, and optimize patient care pathways, particularly within oncology. The company’s solutions are built to partner with biomedical innovators, healthcare providers, and medical societies to advance precision medicine.
ConcertAI offers an array of AI-driven platforms that leverage multi-modal, research-grade data, including electronic medical records (EMR), claims, genomics, and imaging data. Key offerings include the Precision Suite, which provides generative AI-powered applications for health economics and outcomes research (HEOR), medical, and epidemiology teams, enabling dynamic cohort creation and rapid outcomes analysis without extensive programming. Their CARA AI platform is a multi-modal data management, predictive AI, and generative AI solution designed to accelerate research from translational through clinical development.
Furthermore, ConcertAI’s TeraRecon division delivers advanced radiological image visualizations and clinical AI decision augmentation solutions, including specialized suites for pulmonology, neurology, and cardiology. Through its acquisition of CancerLinQ, ConcertAI also provides oncology providers with automated quality solutions aligned with ASCO standards. These integrated solutions aim to support precision oncology, accelerate clinical trials by enabling real-time patient matching, and enhance overall clinical care through data-driven insights and AI-powered automation.
What Physicians Need to Know
For physicians, ConcertAI's tools are designed to significantly reduce administrative burden by automating tasks like patient-to-trial matching and diagnostic reporting, allowing more focus on patient care. Solutions like TeraRecon DETECTu2122 provide more confident diagnoses through reimbursable AI biomarkers and streamline workflows by integrating imaging and EMR data for a comprehensive patient view. The real-time, multi-modal data insights enable evidence-backed clinical decision-making, improved screening, and timely interventions, ultimately enhancing patient access to advanced therapies and supporting value-based care initiatives.
ConcertAI's platforms are built for seamless integration with various healthcare IT systems, including Electronic Health Records (EHRs), claims data, laboratory information systems, and advanced imaging visualization tools. Their CARAaiu2122 platform and TeraRecon Eureka Clinical AI platform are designed to be open to third-party AI algorithms. They also have strategic partnerships with molecular diagnostic companies (e.g., Caris Life Sciences, NeoGenomics, Guardant) and technology leaders like NVIDIA, leveraging NVIDIA NIM microservices and CUDA-X for high-performance AI model deployment and data processing. The integration with the CancerLinQu00ae network further enhances their data capabilities and ASCO-aligned quality solutions.
What the Web Says
ConcertAI is a company focused on accelerating insights and improving outcomes for patients through real-world data, AI technologies, and scientific expertise, particularly in oncology. They offer products like RWD360 for comprehensive clinical data and Patient360 for ready-to-use datasets, as well as an AI platform called Accelerated Clinical Trials (ACT) designed to cut trial timelines and costs. While some employee reviews highlight a supportive environment and good benefits, there are also significant concerns regarding management, job security, and work-life balance.
Overall: MixedStrengths
- Good benefits for employees.
- Supportive work environment.
- Opportunity to learn new things.
- Time and location flexibility.
- Interesting work with medical data, especially for new graduates.
- Products like ACT platform can significantly cut clinical trial timelines and costs.
Limitations
- Poor work-life balance.
- Issues with management, including instability, political internal promotions, and favoritism.
- Lack of job security and frequent layoffs, particularly for US-based data abstractors.
- Concerns about poor quality data and work being sent to India.
- Low ratings for pay and benefits compared to other companies.
- Lack of appreciation or feedback for work.
Based on reviews from: Indeed.com, Great Place To Worku00ae, Elion Health, FeaturedCustomers, G2, Reddit, TechTarget, Capterra, PR Newswire
Last updated: 2026-07-27
Videos
News, demos, and interviews about ConcertAI.
Videos load interactively. If none appear, search YouTube for ConcertAI →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]